Sorafenib Inhibits Proliferation, Migration and Invasion of Breast Cancer Cells.

CONCLUSION: Thus, sorafenib has anti-cancer activity against breast cancer cells and could improve the survival of breast cancer patients by inhibiting their invasive and metastatic properties.
PMID: 32434184 [PubMed - as supplied by publisher]

Source: Oncology - May 19, 2020 Category: Cancer & Oncology Authors: Dattachoudhury S, Sharma R, Kumar A, Jaganathan BG Tags: Oncology Source Type: research